FDA Inspection 1328024 — Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. — FEI 3015282580

The FDA completed an inspection of Mirum Pharmaceuticals, Inc. on Jul 24, 2026 in Foster City, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 24, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Foster City, CA (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.